|
IVIg is a critical plasma derived blood product used to treat an increasing number of indications. The two principal ways IVIg can be accessed in Australia are as follows:
Type of arrangement |
What products are available? |
Who pays for the product? |
How are products accessed? |
What indications are funded? |
National Blood Supply (NBS) Arrangement |
|
Cost is shared between the Commonwealth and the jurisdiction |
Except in the ACT, through ARCBS Transfusion Medicine Services |
Indications included in the Criteria for the Clinical Use of IVIg in Australia (the Criteria) |
Direct Order (DO) Arrangement |
|
Individual jurisdiction bears full cost |
Local arrangements for approval and ordering vary - usually via hospital therapeutics committee |
For indications that are not included under the Criteria |
D = Domestic, I = Imported
This Fact Sheet addresses the contractual arrangements for the supply of IMPORTED IVIg products to meet any shortfalls in the availability of domestically produced IVIg (Intragam®P). To guarantee an adequate, safe and secure supply of this important blood product, the National Blood Authority (NBA) has established contracts for the supply of two imported IVIg products, Octagam® and Flebogamma 5% DIF.
Under the NBS arrangements, indications which meet the Criteria are covered by shared funding arrangements between the Australian Government and the State or Territory Governments. Intragam® P, the domestically produced product, and Octagam®, an imported product, are available under the NBS arrangements through the ARCBS Transfusion Medicine Services.
Under the DO arrangements, approval for funding for indications which do not meet the Criteria may be given by the individual State or Territory. An Approved DO Recipient is a health provider authorised by the State or Territory to order and receive IVIg product. The DO arrangements provide for the direct supply of Octagam® and Flebogamma 5% DIF to Approved DO Recipients.
In circumstances where IVIg cannot be accessed under NBS or DO arrangements, clinicians can choose to access imported IVIg product direct from suppliers at the patient’s cost.
Octapharma Australia Contract
The NBA has contracted with Octapharma Australia for the supply of Octagam® for both the NBS and DO. This contract commenced on 1 December 2007.
Octapharma was one of the suppliers under the previous contractual arrangements and has demonstrated a strong commitment to the Australian market through the provision of high quality blood products and associated services.
Lateral Grifols Contract
The NBA has entered into contractual arrangements with Lateral Grifols Pty Ltd for the supply of Flebogamma 5% DIF for DO arrangements only. This contract commenced on 1 January 2010.
Contract Arrangements for Imported IVIg Products (including DO arrangements)
The contracts, combined, satisfy all Jurisdictional Blood Committee (JBC) mandated parameters and offer Governments exceptional value for money and a range of significant improvements, including:
Price details for Imported IVIg Products (including DO)
Octapharma Australia - Octagam® – NBS and DO
Product |
Price per vial |
Octagam® normal immunoglobulin (human) 2.5g/50ml injection vial |
$218.35 |
Octagam® normal immunoglobulin (human) 5g/100ml injection vial |
$436.70 |
Octagam® normal immunoglobulin (human) 10g/200ml injection vial |
$873.40 |
Lateral Grifols - Flebogamma 5% DIF – DO only
Product |
Price per vial (2010) |
Flebogamma 5% DIF (0.5g/10ml) |
$40.70 |
Flebogamma 5% DIF (2.5g/50ml) |
$203.50 |
Flebogamma 5% DIF (5g/100ml) |
$407.00 |
Flebogamma 5% DIF (10g/200ml) |
$814.00 |
Flebogamma 5% DIF (20g/400ml) |
$1,628.00 |
Ordering Imported IVIg
NBS Arrangements
Requests for IVIg for treating conditions listed in the Criteria (that is NBS supplies) are made to the local Transfusion Medical Service in the ARCBS. In consultation with the clinician, the Transfusion Medicine Services will determine whether the request meets the Criteria and, if so, whether Intragam® P or Octagam® is appropriate. The ARCBS will then supply the product, except in the case of the ACT, whereby Octapharma supplies direct under a standing order to the Canberra Hospital.
Supplier’s Contact Details for Placing Orders for Imported IVIg under NBS arrangements
| SUPPLIER | DISTRIBUTOR |
TELEPHONE |
FACSIMILE |
|
Octapharma Australia |
DHL Exel |
1800 077421 |
1800 358199 |
Direct Order Arrangements
Approved DO Recipients can order DO supplies of Octagam® and Flebogamma 5% DIF directly from Octapharma or Lateral Grifols.
Suppliers’ Contact Details for Placing Orders for Imported IVIg under JDO arrangements
| SUPPLIER | DISTRIBUTOR |
TELEPHONE |
FACSIMILE |
|
Octapharma Australia |
DHL Exel |
1800 077421 |
1800 358199 |
|
Lateral Grifols Pty Ltd |
Lateral Grifols Pty Ltd |
(03) 9535 9333 |
(03) 9535 9300 |
Details of the contractual ordering and delivery arrangements are set out below:
Contracted Ordering and Delivery Arrangements for Imported IVIg
Ordering
Delivery
The Supplier must ensure that the remaining shelf-life of the IVIg Product is no less that 12 months (in the case of Octagam®) and 16 months (in the case of Flebogamma 5% DIF) from the date it is received by an Approved Recipient.
Related Document
Imported IVIg Fact Sheet
(131KB)
Feedback | Privacy | Copyright | Disclaimer | Contact Us
This page last modified on January 19, 2010Agreement Ensures Continuation of Blood Plasma Supplies
Imported IVIg Stakeholder Discussion Paper
Imported IVIg Suppliers Request for Information
Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg)
Employment Opportunities
- APS 3 Corporate Services Support Officer (Part Time)
- APS 4 Executive Support Officer (On-going)
NBA Newsfeed
Subscribe to RSS
-- What is RSS?